- Report
- November 2021
- 65 Pages
Asia Pacific
From €1442EUR$1,500USD£1,237GBP
- Report
- November 2021
- 58 Pages
North America
From €1442EUR$1,500USD£1,237GBP
- Report
- November 2021
- 65 Pages
Middle East, Africa
From €1442EUR$1,500USD£1,237GBP
- Clinical Trials
- June 2020
- 155 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Report
- July 2023
- 85 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- October 2023
- 146 Pages
Global
From €3392EUR$3,528USD£2,910GBP
€3990EUR$4,150USD£3,423GBP
- Report
- April 2023
- 147 Pages
Global
From €5768EUR$5,999USD£4,948GBP
- Report
- September 2021
- 217 Pages
Global
From €5931EUR$6,168USD£5,088GBP
- Report
- October 2023
- 140 Pages
Global
From €2884EUR$2,999USD£2,474GBP
- Report
- April 2023
- 140 Pages
Global
From €5768EUR$5,999USD£4,948GBP
- Book
- February 2023
- 256 Pages
- Book
- January 2020
- 504 Pages
- Book
- January 2020
- 504 Pages
- Book
- December 2019
- 2656 Pages
- Book
- December 2019
- 2656 Pages
- Book
- March 2019
- 552 Pages
- Book
- November 2018
- 528 Pages
Vitiligo is a skin condition characterized by the loss of skin color in patches. It affects people of all ages and skin types, and is caused by the destruction of melanocytes, the cells responsible for skin pigmentation. Treatment options for vitiligo include topical medications, phototherapy, and surgical procedures.
The vitiligo market within the context of dermatology is a growing field, with a range of products and services available to treat the condition. Topical medications, such as corticosteroids and calcineurin inhibitors, are commonly used to reduce the appearance of vitiligo. Phototherapy, such as narrowband UVB, is also used to stimulate the production of melanocytes. Surgical procedures, such as skin grafting and tattooing, are also available to treat vitiligo.
Companies in the vitiligo market include Galderma, Leo Pharma, and Sun Pharma. Other companies, such as Allergan, Mylan, and Teva, also offer products and services for the treatment of vitiligo. Show Less Read more